BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dos Santos Arruda F, Tomé FD, Miguel MP, de Menezes LB, Nagib PRA, Campos EC, Soave DF, Celes MRN. Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game. Curr Pharm Des 2019;25:109-18. [PMID: 30864503 DOI: 10.2174/1381612825666190312110836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cai X, Yang Q, Weng Q, Wang S. pH sensitive doxorubicin-loaded nanoparticle based on Radix pseudostellariae protein-polysaccharide conjugate and its improvement on HepG2 cellular uptake of doxorubicin. Food and Chemical Toxicology 2020;136:111099. [DOI: 10.1016/j.fct.2019.111099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Wang W, Finnegan TJ, Lei Z, Zhu X, Moore CE, Shi K, Badjić JD. Tuning the allosteric sequestration of anticancer drugs for developing cooperative nano-antidotes. Chem Commun 2020;56:1271-4. [DOI: 10.1039/c9cc09373g] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Zhen J, Yu H, Ji H, Cai L, Leng J, Keller BB. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury. Life Sci 2019;239:117070. [PMID: 31751580 DOI: 10.1016/j.lfs.2019.117070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ficai A. Triggering Factors in Drug Delivery Devices. Curr Pharm Des 2019;25:107-8. [PMID: 31198109 DOI: 10.2174/138161282502190514121641] [Reference Citation Analysis]